Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

NCT03449238 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT03449238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03449238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
Lead sponsor
Weill Medical College of Cornell University
Phase
Phase 1/2
Overall status
Recruiting
Start date
November 15, 2018
Completion date
December 31, 2030
Enrollment
41 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, metastatic breast cancer